NO138148C - Fremgangsmaate ved fremstilling av terapeutisk aktivt lithiumsalt av 6alfa-methylprednisolon - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktivt lithiumsalt av 6alfa-methylprednisolon

Info

Publication number
NO138148C
NO138148C NO2058/73A NO205873A NO138148C NO 138148 C NO138148 C NO 138148C NO 2058/73 A NO2058/73 A NO 2058/73A NO 205873 A NO205873 A NO 205873A NO 138148 C NO138148 C NO 138148C
Authority
NO
Norway
Prior art keywords
6alfa
methylprednisolone
procedure
preparation
lithium salt
Prior art date
Application number
NO2058/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO138148B (no
Inventor
Simone Heurtaux
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO138148B publication Critical patent/NO138148B/no
Publication of NO138148C publication Critical patent/NO138148C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NO2058/73A 1972-05-19 1973-05-18 Fremgangsmaate ved fremstilling av terapeutisk aktivt lithiumsalt av 6alfa-methylprednisolon NO138148C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7218035A FR2193576B1 (xx) 1972-05-19 1972-05-19

Publications (2)

Publication Number Publication Date
NO138148B NO138148B (no) 1978-04-03
NO138148C true NO138148C (no) 1978-07-12

Family

ID=9098837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2058/73A NO138148C (no) 1972-05-19 1973-05-18 Fremgangsmaate ved fremstilling av terapeutisk aktivt lithiumsalt av 6alfa-methylprednisolon

Country Status (25)

Country Link
JP (1) JPS5212777B2 (xx)
AT (1) AT325221B (xx)
AU (1) AU473292B2 (xx)
BE (1) BE799615A (xx)
CA (1) CA977746A (xx)
CH (1) CH572068A5 (xx)
CS (1) CS165956B2 (xx)
DD (1) DD104787A5 (xx)
DK (1) DK133683B (xx)
EG (1) EG11080A (xx)
ES (1) ES414870A1 (xx)
FI (1) FI52588C (xx)
FR (1) FR2193576B1 (xx)
GB (1) GB1375357A (xx)
HU (1) HU165993B (xx)
IE (1) IE37657B1 (xx)
IL (1) IL42250A (xx)
NL (1) NL7306962A (xx)
NO (1) NO138148C (xx)
PH (1) PH12351A (xx)
PL (1) PL85506B1 (xx)
SE (1) SE399711B (xx)
SU (1) SU493961A3 (xx)
YU (1) YU35037B (xx)
ZA (1) ZA733340B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112816A (ja) * 1975-04-03 1976-01-31 Wakao Kanao Tairubaripurekyasutokonkuriitono seizohoho
JPS51122118A (en) * 1975-04-15 1976-10-26 Wakao Kanao Production of tiled precast concrete
US4948533A (en) * 1984-03-28 1990-08-14 The Upjohn Company 11a-hydroxy steroid diester
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids

Also Published As

Publication number Publication date
AT325221B (de) 1975-10-10
EG11080A (en) 1977-04-30
ES414870A1 (es) 1976-05-01
AU473292B2 (en) 1976-06-17
SE399711B (sv) 1978-02-27
YU35037B (en) 1980-06-30
FR2193576A1 (xx) 1974-02-22
DE2325358B2 (de) 1976-01-29
AU5590073A (en) 1974-11-21
DE2325358A1 (de) 1973-11-29
IL42250A (en) 1977-06-30
DK133683B (da) 1976-06-28
FI52588C (fi) 1977-10-10
FR2193576B1 (xx) 1975-08-08
DD104787A5 (xx) 1974-03-20
JPS4948653A (xx) 1974-05-11
PH12351A (en) 1979-01-29
SU493961A3 (ru) 1975-11-28
CA977746A (en) 1975-11-11
NO138148B (no) 1978-04-03
IE37657B1 (en) 1977-09-14
JPS5212777B2 (xx) 1977-04-09
CH572068A5 (xx) 1976-01-30
GB1375357A (xx) 1974-11-27
HU165993B (xx) 1974-12-28
IE37657L (en) 1973-11-19
BE799615A (fr) 1973-11-16
ZA733340B (en) 1974-11-27
DK133683C (xx) 1976-11-15
CS165956B2 (xx) 1975-12-22
FI52588B (xx) 1977-06-30
NL7306962A (xx) 1973-11-21
YU127873A (en) 1979-12-31
IL42250A0 (en) 1973-07-30
PL85506B1 (xx) 1976-04-30

Similar Documents

Publication Publication Date Title
NO144885C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO145883C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO145242C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme o-substituerte 7beta-acylamino-3-cefem-3-ol-4-karboksylsyre-forbindelser
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
NO138148C (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt lithiumsalt av 6alfa-methylprednisolon
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE385699B (sv) Forfarande for framstellning av bensensulfonylkarbamider
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO139890C (no) Fremgangsmaate ved fremstilling av n5 -methyltetrahydrohomofolinsyre
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe